![Immusoft](https://www.adcreviews.com/wp-content/uploads/2022/09/Immusoft-300x158.jpg)
FDA Approves Engineered B Cell Therapy ISP-001 Clinical
On September 1, Immusoft announced that the FDA has approved the clinical trial application of ISP-001 for mucopolysaccharidosis type I, which is the world’s first
On September 1, Immusoft announced that the FDA has approved the clinical trial application of ISP-001 for mucopolysaccharidosis type I, which is the world’s first